How to Use Ganirelix
Complete guide to Ganirelix dosing, administration, timing, and protocol recommendations.
Quick Overview
Ganirelix is a GnRH antagonist used in IVF to stop the body from ovulating too early while the ovaries are being stimulated. The FDA approved it in July 1999 (originally from Organon, now also sold as generics such as Fyremadel), and it comes as a ready-to-use 250 mcg prefilled syringe. It does the same job as cetrorelix, with a slightly longer half-life. It is a boring, reliable fertility drug, and that is a compliment.
Dosing Guidelines
Common Dose
250 mcg once daily during IVF stimulation (labeled dose)
Frequency
Once daily
Dose Range
250 mcg daily
Note: Labeled prescription dose, used only inside a monitored IVF cycle with FSH and ultrasound tracking. Higher doses were not better in the dose-finding trial. Use outside fertility treatment has no established benefit.
Administration Method
Subcutaneous injection from a prefilled syringe
Best Time to Take
Same time each day, usually starting around day 6 of FSH
The pivotal trials gave it in the morning from day 6 of FSH stimulation; steady once-daily dosing keeps LH suppressed until the trigger shot.
Protocol Duration
A few days per IVF cycle (mean 5.4 days in trials, range 2-14)
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Pelvic or abdominal pain (4.8%)
- •Headache (3%)
- •Ovarian hyperstimulation syndrome (2.4%, tied to the overall IVF stimulation)
- •Vaginal bleeding
- •Injection site reactions
Frequently Asked Questions
What is the recommended dose for Ganirelix?
250 mcg once daily during IVF stimulation (labeled dose)
How do you administer Ganirelix?
Subcutaneous injection from a prefilled syringe
When is the best time to take Ganirelix?
Same time each day, usually starting around day 6 of FSH
How long should you use Ganirelix?
A few days per IVF cycle (mean 5.4 days in trials, range 2-14)
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.